To identify suitable predictive biomarkers that could complement TNM staging, here we used the expression data from the GDC-SKCM cohort of The Cancer Genome Atlas (TCGA) project [40] and other MM datasets to analyze the relationship between MGRN1 expression, alone or combined with several known MM biomarkers, and patient OS. Here, MGRN1 is linked to Miyoshi myopathy.